Akebia Therapeutics Receives $41,000,000 Series C Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0311bb03-64fe-4199-95f5-4523174b9bfd&Preview=1 - Date
6/5/2013 - Company Name
Akebia Therapeutics - Mailing Address
9987 Carver Rd. Cincinnati, OH 45242 - Company Description
Akebia Therapeutics is a venture-backed start-up pharmaceutical company with a focus on treatments for ischemia and improvement of vascular disease. - Website
http://www.akebia.com - Transaction Type
Venture Equity - Transaction Amount
$41,000,000 - Transaction Round
Series C - Proceeds Purposes
The proceeds of this financing will be used to fund the ongoing development of AKB-6548, the Company’s lead clinical compound. - M&A Terms
- Venture Investor
Satter Investment Management - Venture Investor
Novartis Venture Fund - Venture Investor
Kearny Venture Partners - Venture Investor
Venture Investors - Venture Investor
Athenian Venture Partners - Venture Investor
Triathlon Medical Ventures - Venture Investor
AgeChem Venture Fund - Venture Investor
Sigvion Capital
